Survey
The CC chemokine CCL20 and its receptor CCR6

https://doi.org/10.1016/S1359-6101(03)00049-2Get rights and content

Abstract

CCL20, alternatively named liver and activation-regulated chemokine (LARC), macrophage inflammatory protein-3α (MIP-3α) or Exodus-1, is the only chemokine known to interact with CC chemokine receptor 6 (CCR6), a property shared with the antimicrobial β-defensins. The ligand-receptor pair CCL20-CCR6 is responsible for the chemoattraction of immature dendritic cells (DC), effector/memory T-cells and B-cells and plays a role at skin and mucosal surfaces under homeostatic and inflammatory conditions, as well as in pathology, including cancer and rheumatoid arthritis. In this review, the discovery, the gene and protein structure, the in vitro biological activities, the cell and inducer specific expression and the tissue distribution of CCL20 and CCR6 are discussed.

Introduction

Chemokines constitute a family of structurally related chemotactic cytokines that direct the migration of leukocytes throughout the body, both under physiological and inflammatory conditions [1]. Furthermore, they are involved in processes like angiogenesis, morphogenesis, autoimmunity, tumor growth and metastasis. Generally, chemokines exert their various biological functions by activating 7-transmembrane-domain G protein-coupled receptors on their target cells [2]. According to the presence and the relative position of the NH2-terminal Cys residues, chemokines are structurally grouped into the CC, CXC, CX3C and C chemokines. A first generation of chemokines was mainly discovered on the basis of their chemotactic properties. Most of them are believed to play a central role in the recruitment of the soldiers of the immune system at inflammatory sites upon strong induction in a large spectrum of cell types. Since 1996, a second generation of chemokines emerged largely on account of developments in bioinformatics and expressed sequence tag (EST) databases. Most of these chemokines are expressed constitutively but selectively in some specific cell types and are assumed to orchestrate the homeostatic trafficking of leukocytes and the organization of lymphoid tissues [3]. However, some second-generation chemokines, such as CCL20, are expected to act both as constitutive/homeostatic and inducible/inflammatory chemokines, depending on the conditions [4].

Section snippets

Discovery of CCL20

Human CCL20 was simultaneously reported by three different groups as the first chemokine discovered through bioinformatics-based searches of DNA databases and automated sequencing techniques. Screening the public GenBank EST database with amino acid and nucleotide sequences of various known CC chemokines, Hieshima et al. identified five partial, overlapping cDNA sequences (three from pancreatic islets, one from fetal lung and one from HepG2 hepatocytic cells) likely to encode a novel human CC

Structure of CCL20 gene

In contrast to the first-generation CC chemokines genes, all clustered at chromosome 17q11.2, the human CCL20 gene (SCYA20) was mapped to chromosome 2q33-37 [5], [12]. Since CCL20 is only distantly related to other CC chemokines, its gene may have been generated before amplification of the CC chemokines on chromosome 17. Intron/exon junctions of the CC chemokine subfamily members are normally highly conserved, with the majority containing three exons and two introns. However, the CCL20 gene,

Structure of CCL20 protein

The full-length CCL20 cDNA contains an open reading frame (ORF) encoding a 96-amino acid precursor protein. The NH2-terminus of the corresponding amino acid sequence is highly hydrophobic and is consistent with a typical signal sequence. The cleavage site has been predicted to be located between the two Ala residues at position 26 and 27 of the precursor protein, theoretically giving rise to a mature protein of 70 amino acids, CCL20(1-70) [5], [6]. However, the pancreas-derived ESTs that were

Discovery of CCR6, the selective receptor for CCL20

In 1996, Zaballos et al. discovered through a degenerate primer strategy a putative chemokine receptor, CKR-L3, but failed to identify a functional ligand for this lymphocyte-specific receptor [26]. Liao et al. cloned the genomic sequence of this orphan receptor, alternatively named STRL22 [27], from tumor-infiltrating lymphocytes (TIL) and the same receptor was also deposited as DRY6 and GPR-CY4 in the GenBank database. Baba et al. were the first to identify CCL20 as a highly selective and

CCR6 expression and spectrum of in vitro biological activities of CCL20

With the availability of commercial Northern blot filters covering different human tissues, CCR6 was immediately demonstrated to be constitutively expressed in both lymphoid and non-lymphoid organs: predominantly in spleen, lymph nodes, appendix and pancreas, and to a lesser degree in peripheral blood leukocytes, thymus, small intestine, fetal liver and testis [26], [27], [28], [30]. Furthermore, CCR6 transcripts were originally reported in lymphocytes and in DC, but not in monocytes [21], [26]

CCL20 expression

Despite the designation LARC, constitutive expression of CCL20 was originally demonstrated in several tissues in addition to liver (mainly in mucosa-associated and lymphoid tissues) with the use of commercially available multi-tissue Northern blot filters (Table 2). Simultaneously, the inducibility of CCL20 was evidenced in different cell types, primarily in monocytic cells (Table 3). However, the spectrum of cellular sources, inducers as well as CCL20-expressing tissues broadened rapidly

Potential role of CCL20 and CCR6 in homeostasis and pathology

The findings on CCL20 expression in a broad spectrum of cell and tissue types and on the variety of CCL20-inducing agents, suggest that CCL20 and CCR6 are involved in both normal and pathological processes (Table 4), especially at epithelial surfaces. Here, the potential role of CCL20 and CCR6 in skin and mucosal immunity, in cancer and in rheumatoid arthritis will be highlighted.

Acknowledgements

This work was supported by the Fund for Scientific Research of Flanders (FWO-Vlaanderen), the Concerted Research Actions of the Regional Government of Flanders, the InterUniversity Attraction Pole Initiative of the Belgian Federal Government and the Quality of Life Program of the European Community. S.S. holds a fellowship from the FWO-Vlaanderen. We thank Prof. J. Balzarini (K.U. Leuven, Belgium), Prof. A. Billiau (K.U. Leuven, Belgium), Prof. P. Hoet (K.U. Leuven, Belgium), Prof. G. Laureys

References (135)

  • J.H. Kwon et al.

    ESE-1, an enterocyte-specific Ets transcription factor, regulates MIP-3α gene expression in Caco-2 human colonic epithelial cells

    J. Biol. Chem.

    (2003)
  • G. Shaw et al.

    A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation

    Cell

    (1986)
  • D.M. Hoover et al.

    The structure of human macrophage inflammatory protein-3α/CCL20: linking antimicrobial and CC chemokine receptor-6-receptor binding activities with human β-defensins

    J. Biol. Chem.

    (2002)
  • J.M. Perez-Canadillas et al.

    NMR solution structure of murine CCL20/MIP-3α, a chemokine that specifically chemoattracts immature dendritic cells and lymphocytes through its highly specific interaction with the β-chemokine receptor CCR6

    J. Biol. Chem.

    (2001)
  • A. Zaballos et al.

    Molecular cloning and RNA expression of two new human chemokine receptor-like genes

    Biochem. Biophys. Res. Commun.

    (1996)
  • F. Liao et al.

    Cloning of STRL22, a new human gene encoding a G-protein-coupled receptor related to chemokine receptors and located on chromosome 6q27

    Genomics

    (1997)
  • M. Baba et al.

    Identification of CCR6, the specific receptor for a novel lymphocyte-directed CC chemokine LARC

    J. Biol. Chem.

    (1997)
  • F. Liao et al.

    STRL22 is a receptor for the CC chemokine MIP-3α

    Biochem. Biophys. Res. Commun.

    (1997)
  • S. Godefroy et al.

    A combination of MIP-3α and TGF-β1 is required for the attraction of human Langerhans precursor cells through a dermal–epidermal barrier

    Eur. J. Cell. Biol.

    (2001)
  • K. Christopherson et al.

    Regulation of naive fetal T-cell migration by the chemokines Exodus-2 and Exodus-3

    Immunol. Lett.

    (1999)
  • C.H. Kim et al.

    Trafficking machinery of NKT cells: shared and differential chemokine receptor expression among Vα24+Vβ11+ NKT cell subsets with distinct cytokine-producing capacity

    Blood

    (2002)
  • R. Krzysiek et al.

    Regulation of CCR6 chemokine receptor expression and responsiveness to macrophage inflammatory protein-3α/CCL20 in human B cells

    Blood

    (2000)
  • M. Casamayor-Palleja et al.

    BCR ligation reprograms B cells for migration to the T zone and B-cell follicle sequentially

    Blood

    (2002)
  • M.J. Robertson et al.

    Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines

    Cell Immunol.

    (2000)
  • S. Yamashiro et al.

    Expression of CCR6 and CD83 by cytokine-activated human neutrophils

    Blood

    (2000)
  • D.N. Hart

    Dendritic cells: unique leukocyte populations which control the primary immune response

    Blood

    (1997)
  • T. Jakob et al.

    Multistep navigation of Langerhans/dendritic cells in and out of the skin

    J. Allergy Clin. Immunol.

    (2001)
  • R. Hromas et al.

    The Exodus subfamily of CC chemokines inhibits the proliferation of chronic myelogenous leukemia progenitors

    Blood

    (2000)
  • M.B. Dwinell et al.

    Chemokine receptor expression by human intestinal epithelial cells

    Gastroenterology

    (1999)
  • L. Eckmann et al.

    Analysis by high density cDNA arrays of altered gene expression in human intestinal epithelial cells in response to infection with the invasive enteric bacteria Salmonella

    J. Biol. Chem.

    (2000)
  • M. Tohyama et al.

    Differentiated keratinocytes are responsible for TNF-α regulated production of macrophage inflammatory protein 3α/CCL20, a potent chemokine for Langerhans cells

    J. Dermatol. Sci.

    (2001)
  • T. Suzuki et al.

    Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE

    Blood

    (2000)
  • S. Matikainen et al.

    Influenza A and sendai viruses induce differential chemokine gene expression and transcription factor activation in human macrophages

    Virology

    (2000)
  • Y. Shimizu et al.

    CC-chemokine receptor 6 and its ligand macrophage inflammatory protein 3α might be involved in the amplification of local necroinflammatory response in the liver

    Hepatology

    (2001)
  • S. Wakahara et al.

    Gene expression profiles for FcεRI, cytokines and chemokines upon FcεRI activation in human cultured mast cells derived from peripheral blood

    Cytokine

    (2001)
  • P.M. Murphy et al.

    International union of pharmacology. XXII. Nomenclature for chemokine receptors

    Pharmacol. Rev.

    (2000)
  • A. Zlotnik et al.

    Recent advances in chemokines and chemokine receptors

    Crit. Rev. Immunol.

    (1999)
  • D.L. Rossi et al.

    Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3α and MIP-3β

    J. Immunol.

    (1997)
  • S. Sugita et al.

    Induction of macrophage-inflammatory protein-3α gene expression by TNF-dependent NF-κB activation

    J. Immunol.

    (2002)
  • A. Izadpanah et al.

    Regulated MIP-3α/CCL20 production by human intestinal epithelium: mechanism for modulating mucosal immunity

    Am. J. Physiol. Gastroint Liver Physiol.

    (2001)
  • Y. Imaizumi et al.

    Human T cell leukemia virus type-I Tax activates human macrophage inflammatory protein-3α/CCL20 gene transcription via the NF-κB pathway

    Int. Immunol.

    (2002)
  • Y. Tanaka et al.

    Selective expression of liver and activation-regulated chemokine (LARC) in intestinal epithelium in mice and humans

    Eur. J. Immunol.

    (1999)
  • S. Fujiie et al.

    Proinflammatory cytokines induce liver and activation-regulated chemokine/macrophage inflammatory protein-3α/CCL20 in mucosal epithelial cells through NF-κB [correction of NK-κB]

    Int. Immunol.

    (2001)
  • C.A. Power et al.

    Cloning and characterization of a specific receptor for the novel CC chemokine MIP-3α from lung dendritic cells

    J. Exp. Med.

    (1997)
  • E. Schutyser et al.

    Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3α from normal and transformed cells

    J. Immunol.

    (2000)
  • O. Yoshie et al.

    Novel lymphocyte-specific CC chemokines and their receptors

    J. Leukoc. Biol.

    (1997)
  • D.R. Greaves et al.

    CCR6, a CC chemokine receptor that interacts with macrophage inflammatory protein 3α and is highly expressed in human dendritic cells

    J. Exp. Med.

    (1997)
  • L.-S. Ai et al.

    Mutating the four extracellular cysteines in the chemokine receptor CCR6 reveals their differing roles in receptor trafficking, ligand binding, and signaling

    Biochemistry

    (2002)
  • J. Banchereau et al.

    Immunobiology of dendritic cells

    Annu. Rev. Immunol.

    (2000)
  • M.-C. Dieu et al.

    Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites

    J. Exp. Med.

    (1998)
  • Cited by (0)

    View full text